Axogen, Inc. — Director's Dealing 2022

Feb 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2022-02-15

Reporting Person: Billet Isabelle (Chief Strategy and BD Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-15	Common Stock	A	1325	—	Acquired	16163	Direct
2022-02-15	Common Stock	F	447	$8.42	Disposed	15716	Direct

Footnotes

F1: This reflects the number of shares that became vested as of February 15, 2022 upon the attainment of certain performance criteria.

F2: Includes 654 shares acquired under the Axogen stock purchase plan on December 31, 2021.

F3: The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2022.